# Giftify, Inc.: overview GIFT · Nasdaq · CIK 1760233 · [Consumer discretionary](/sectors/consumer-discretionary.md) · fiscal year ends Dec 31 Pages: [Overview](/companies/gift.md) · [Financials](/companies/gift/financials.md) · [Filings](/companies/gift/filings.md) · [Insiders](/companies/gift/insiders.md) Latest reported revenue: [$21.7m](/filings/0001493152-26-035759.md) for Q2 FY2026, three months to 2026-06-30, from the 10-Q filed Aug 3, 2026 (XBRL us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax, accession 0001493152-26-035759). ## Last eight quarters | Line item | Unit | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Revenue | $m | [23.2](/filings/0001493152-25-021421.md) | [24.2 d](/filings/0001493152-26-016199.md) | [22.3](/filings/0001493152-26-022415.md) | [20.9](/filings/0001493152-26-035759.md) | [18.8](/filings/0001493152-25-021421.md) | [21.2 d](/filings/0001493152-26-016199.md) | [21.4](/filings/0001493152-26-022415.md) | [21.7](/filings/0001493152-26-035759.md) | | Gross margin | % | [12.9%](/filings/0001493152-25-021421.md) | [15.0% d](/filings/0001493152-26-016199.md) | [16.1%](/filings/0001493152-26-022415.md) | [18.4%](/filings/0001493152-26-035759.md) | [20.0%](/filings/0001493152-25-021421.md) | [20.3% d](/filings/0001493152-26-016199.md) | [19.9%](/filings/0001493152-26-022415.md) | [20.2%](/filings/0001493152-26-035759.md) | | Operating margin | % | [(16.3%)](/filings/0001493152-25-021421.md) | [(17.2%) d](/filings/0001493152-26-016199.md) | [(14.2%)](/filings/0001493152-26-022415.md) | [(12.3%)](/filings/0001493152-26-035759.md) | [(13.2%)](/filings/0001493152-25-021421.md) | [(10.0%) d](/filings/0001493152-26-016199.md) | [(12.5%)](/filings/0001493152-26-022415.md) | [(5.8%)](/filings/0001493152-26-035759.md) | | Net margin | % | [(17.5%)](/filings/0001493152-25-021421.md) | [(15.9%) d](/filings/0001493152-26-016199.md) | [(14.4%)](/filings/0001493152-26-022415.md) | [(12.4%)](/filings/0001493152-26-035759.md) | [(13.0%)](/filings/0001493152-25-021421.md) | [(10.6%) d](/filings/0001493152-26-016199.md) | [(12.4%)](/filings/0001493152-26-022415.md) | [(5.7%)](/filings/0001493152-26-035759.md) | | Diluted EPS | $ per share | [(0.16)](/filings/0001493152-25-021421.md) | not reported | [(0.11)](/filings/0001493152-26-022415.md) | [(0.09)](/filings/0001493152-26-035759.md) | [(0.08)](/filings/0001493152-25-021421.md) | not reported | [(0.08)](/filings/0001493152-26-022415.md) | [(0.04)](/filings/0001493152-26-035759.md) | | Free cash flow | $m | [(0.0) d](/filings/0001493152-25-021421.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | - Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure. - Gross margin (gross profit / revenue). XBRL Gross profit: us-gaap:GrossProfit; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure. - Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure. - Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure. - Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquireProductiveAssets. Derived values: 9-month figure less the 6-month figure; 12-month figure less the 9-month figure; 6-month figure less the 3-month figure. ## Last five fiscal years | Line item | Unit | FY (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-29) | FY2024 (2024-12-31) | FY2025 (2025-12-31) | | --- | --- | ---: | ---: | ---: | ---: | ---: | | Revenue | $m | [3.3](/filings/0001493152-23-006895.md) | [4.4](/filings/0001493152-23-006895.md) | [87.1](/filings/0001641172-25-005415.md) | [88.9](/filings/0001493152-26-016199.md) | [83.2](/filings/0001493152-26-016199.md) | | Gross margin | % | not reported | [235.8%](/filings/0001493152-24-014101.md) | [12.0%](/filings/0001641172-25-005415.md) | [14.8%](/filings/0001493152-26-016199.md) | [18.6%](/filings/0001493152-26-016199.md) | | Operating margin | % | [(165.7%)](/filings/0001493152-23-006895.md) | [(126.0%)](/filings/0001493152-24-014101.md) | [(3.5%)](/filings/0001641172-25-005415.md) | [(20.7%)](/filings/0001493152-26-016199.md) | [(12.4%)](/filings/0001493152-26-016199.md) | | Net margin | % | [(150.2%)](/filings/0001493152-23-006895.md) | [(187.3%)](/filings/0001493152-24-014101.md) | [(0.1%)](/filings/0001641172-25-005415.md) | [(21.2%)](/filings/0001493152-26-016199.md) | [(12.6%)](/filings/0001493152-26-016199.md) | | Diluted EPS | $ per share | not reported | [(0.57)](/filings/0001493152-24-014101.md) | [(0.01)](/filings/0001641172-25-005415.md) | [(0.73)](/filings/0001493152-26-016199.md) | [(0.35)](/filings/0001493152-26-016199.md) | | Free cash flow | $m | not reported | [(1.1)](/filings/0001493152-24-014101.md) | [(1.4)](/filings/0001641172-25-005415.md) | not reported | not reported | - Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. - Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax; Gross profit: us-gaap:GrossProfit. - Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. - Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. - Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquireProductiveAssets. Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing. ## Insider purchases and sales The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/gift/insiders.md) None in coverage. ## Funds that report holding it From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md) | Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before | | --- | --- | ---: | ---: | --- | --- | | [SECURITY BENEFIT LIFE INSURANCE CO /KS/](/funds/869772.md) | 2026-06-30 | $2.3m | 2,470,479 | | Unchanged | | [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $364.6k | 384,652 | | Added +1,800 | | [GEODE CAPITAL MANAGEMENT, LLC](/funds/1214717.md) | 2026-06-30 | $171.4k | 180,769 | | Reduced −27,208 | | [Henrickson Nauta Wealth Advisors, Inc.](/funds/1903859.md) | 2026-06-30 | $135.0k | 142,398 | | Unchanged | | [BLAIR WILLIAM & CO/IL](/funds/902367.md) | 2026-06-30 | $121.9k | 128,553 | | Unchanged | | [VANGUARD FIDUCIARY TRUST CO](/funds/933478.md) | 2026-06-30 | $95.4k | 100,606 | | Unchanged | | [ELEVATION POINT WEALTH PARTNERS, LLC](/funds/1744349.md) | 2026-06-30 | $94.8k | 100,000 | | Unchanged | | [BlackRock, Inc.](/funds/2012383.md) | 2026-06-30 | $81.7k | 86,196 | | Added +22,744 | | [CITADEL ADVISORS LLC](/funds/1423053.md) | 2026-06-30 | $46.1k | 48,669 | | New +48,669 | | [NORTHERN TRUST CORP](/funds/73124.md) | 2026-06-30 | $37.1k | 39,094 | | Added +9,964 | ## Recent filings [All 147 filings](/companies/gift/filings.md) | Filed | Accepted | Form | What it is | Accession | | --- | --- | --- | --- | --- | | 2026-10-20 | 20:30 ET | [DEF 14A](/filings/0001493152-26-047765.md) | Proxy statement, period 2026-10-20 | 0001493152-26-047765 | | 2026-08-07 | 20:00 ET | [8-K](/filings/0001493152-26-036559.md) | 3.01 Delisting notice; 9.01 Financial statements and exhibits | 0001493152-26-036559 | | 2026-08-03 | 13:20 ET | [10-Q](/filings/0001493152-26-035759.md) | Quarterly report, period 2026-06-30 | 0001493152-26-035759 | | 2026-05-12 | 12:30 ET | [10-Q](/filings/0001493152-26-022415.md) | Quarterly report, period 2026-03-31 | 0001493152-26-022415 | | 2026-04-28 | 12:30 ET | [8-K](/filings/0001493152-26-019253.md) | 3.01 Delisting notice; 9.01 Financial statements and exhibits | 0001493152-26-019253 | | 2026-04-10 | 21:00 ET | [10-K/A](/filings/0001493152-26-016199.md) | Annual report, amended, period 2025-12-31 | 0001493152-26-016199 | | 2026-03-27 | 21:00 ET | [8-K](/filings/0001493152-26-013237.md) | 3.01 Delisting notice; 9.01 Financial statements and exhibits | 0001493152-26-013237 | | 2026-03-18 | 12:35 ET | [10-K](/filings/0001493152-26-010887.md) | Annual report, period 2025-12-31 | 0001493152-26-010887 | | 2025-11-10 | 13:36 ET | [10-Q](/filings/0001493152-25-021421.md) | Quarterly report, period 2025-09-30 | 0001493152-25-021421 | | 2025-10-20 | 20:05 ET | [8-K](/filings/0001493152-25-018639.md) | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001493152-25-018639 | ## Latest annual report [Form 10-K for the fiscal year ended Dec 31, 2025](/filings/0001493152-26-010887.md), filed Mar 18, 2026. ## Forecast league Q3 FY2026, the quarter ended 2026-09-30, is open for forecasts until the first results filing for it is accepted by EDGAR. Results are due by \[object Promise\]. [Forecast this quarter](/leagues/2026q3/targets/b3fbb8d5-cc0c-462c-89d1-71bd95703474) ## About the filer - CIK: 1760233 - Tickers: GIFT - Exchange: Nasdaq - SIC code: 5961 Retail-Catalog & Mail-Order Houses - State of incorporation: DE - Filer category:
Emerging growth company Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 24, 2026, 15:47 ET. No prices; not investment advice.